Teachers Retirement System of The State of Kentucky Grows Position in GE HealthCare Technologies Inc. $GEHC

Teachers Retirement System of The State of Kentucky boosted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report) by 19.7% in the third quarter, Holdings Channel.com reports. The institutional investor owned 352,124 shares of the company’s stock after acquiring an additional 58,000 shares during the period. Teachers Retirement System of The State of Kentucky’s holdings in GE HealthCare Technologies were worth $26,445,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Mathes Company Inc. grew its stake in shares of GE HealthCare Technologies by 2.0% in the third quarter. Mathes Company Inc. now owns 47,354 shares of the company’s stock worth $3,556,000 after acquiring an additional 907 shares during the period. Focus Partners Advisor Solutions LLC bought a new position in GE HealthCare Technologies during the third quarter valued at approximately $362,000. 111 Capital boosted its holdings in GE HealthCare Technologies by 15.8% in the third quarter. 111 Capital now owns 3,707 shares of the company’s stock worth $278,000 after purchasing an additional 506 shares during the last quarter. WASHINGTON TRUST Co bought a new stake in GE HealthCare Technologies in the 3rd quarter worth approximately $226,000. Finally, Waverton Investment Management Ltd grew its position in GE HealthCare Technologies by 2.8% in the 3rd quarter. Waverton Investment Management Ltd now owns 1,086,668 shares of the company’s stock worth $81,582,000 after purchasing an additional 29,897 shares during the period. Institutional investors own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on GEHC shares. Wells Fargo & Company raised their price target on GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Barclays increased their target price on GE HealthCare Technologies from $86.00 to $87.00 and gave the company an “equal weight” rating in a report on Friday, February 6th. Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Monday, December 29th. Jefferies Financial Group lifted their price target on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a research note on Thursday, December 11th. Finally, BTIG Research raised their target price on GE HealthCare Technologies from $87.00 to $91.00 and gave the stock a “buy” rating in a report on Wednesday, February 4th. Seven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of “Hold” and a consensus target price of $92.50.

Read Our Latest Research Report on GEHC

GE HealthCare Technologies Stock Performance

Shares of NASDAQ GEHC opened at $80.16 on Tuesday. The stock has a market cap of $36.53 billion, a PE ratio of 17.58, a price-to-earnings-growth ratio of 1.85 and a beta of 1.03. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $89.77. The firm has a fifty day moving average price of $82.31 and a 200-day moving average price of $78.51. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 1.13.

GE HealthCare Technologies (NASDAQ:GEHCGet Free Report) last issued its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.04. The company had revenue of $5.70 billion during the quarter, compared to the consensus estimate of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. GE HealthCare Technologies’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be given a dividend of $0.035 per share. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.07%.

GE HealthCare Technologies Company Profile

(Free Report)

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

Read More

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report).

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.